What smart money is saying about BASF
BAS.DE
No fund has written a full thesis on BASF in our archive, but 2 fund letters report a position in it — most recently Brown Advisory International Value Select Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
2
Reported positions
0
Bought
1
Sold
3
Letters
Position history
Between Q2 2026 and Q3 2026, 2 fund letters reported a position in BASF — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 1 | 0 |
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 2 positions · 1 move
- September 2026
“ BASF: While we are attracted to the company’s exposure to a depressed chemicals cycle and the potential for margins and returns to normalise over time, we see increased capital allocation risk in China and structural disadvantages from its European cost base. Given the level of cyclicality and the more attractive opportunities elsewhere in the portfolio, we chose to exit the position during the month.”
BASF - June 2026
“German chemical producer BASF declined as first-quarter results reflected continued weakness in European chemicals and left full-year guidance unchanged, with analyst downgrades and mounting concerns over structural overcapacity weighing on the margin outlook through the quarter.”
BASF
Also mentioned · 1
These funds discuss BASF — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedTAMIM Fund: Global High ConvictionSeptember 2026
“Then things became more interesting. In late September BASF confirmed a non binding approach regarding a possible takeover, and Evonik's board reportedly rejected an initial offer of €22.15 a share, valuing the equity at around €10.3 billion.”
BASF
Read the letters behind these BASF positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger